Prognostic impact of sarcopenia in patients with hepatocellular carcinoma treated with PD-1 inhibitor.

Yusheng GuoYan-Qiao RenFeihong WuXiangjun DongChuansheng Zheng

Published in: Therapeutic advances in gastroenterology (2022)

HCC patients with sarcopenia tended to have higher levels of inflammation and lower levels of albumin than patients without sarcopenia. Sarcopenia is associated with a shorter PFS in HCC patients treated with PD-1 inhibitor.

Keyphrases

skeletal muscle
end stage renal disease
community dwelling
newly diagnosed
ejection fraction
chronic kidney disease
oxidative stress
peritoneal dialysis
prognostic factors
patient reported